Overview
We provide customized research solutions to life sciences and healthcare clients to help them understand the market and competitive landscape, improve efficiencies and productivity, conduct pipeline analysis, assess therapeutic areas and formulate effective developmental and commercial strategies.
Our engagements are with large and mid-tier pharmaceutical, biotechnology, medical devices and consumer health companies and healthcare consulting firms operating across the globe. We offer flexible, scaleable, and cost-effective strategic research solutions across key domains, covering a wide spectrum of therapeutic areas.
Our clients have gained tangible business value through our unparalleled domain expertise, customised research offerings and effective execution capabilities.
Support we offer
How we are different
Broad spectrum of service offerings supporting a number of functions within pharma, bio-pharma and medical device companies
Long term partnerships to drive efficiency in client operations
Ability to scale up or down based on requirements, both current and future
International delivery centers available to provide round the clock support with multi-lingual capabilities
Structured governance process and high data security through sustained investment from Acuity Knowledge Partners
Integrating data analytics’ capabilities with domain experts providing insights analyzing large unstructured data
What we have done
Product launch strategy for European biopharmaceutical company
What we are proud of
Identified geographical concentration of demand
Designed optimal distribution channel configuration
Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of
Benchmarked therapeutic areas with high clinical and market potential
Developed potential market scenarios based on client needs
Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of
Identified opportunities for expansion and plausible revenue streams
Identified potential geographies and activation levers from competitors
Assessing viability of entering the NSCLC market
What we are proud of
Evaluated unmet needs to identify potential entry points
Conducted a deep-dive study of key assets and key players
Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of
Analysed potential for entry into the GCC pharmaceutical market
Assessed possible market drivers and barriers to entry
Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of
Optimised vendor-associated costs across geographies
Identified billing arrangements across law firms
Research on a multiple sclerosis drug with help from global neurologists
What we are proud of
Assessed the target market size, key competitors and current pricing range
Enabled the client to take informed decisions thereby increasing market penetration
Procurement in non-Food FMCG Industry
What we are proud of
10-15%
sourcing cost reductions by
Macro-economics/ regulation
Our perspective on Life Science Healthcare Research
January 28, 2021
Thank you for sharing your details
Share this on
